HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

RELX

RELX PLC (NYSE)

Industrials — Specialty Business Services

RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk, as well as a portfolio of commercial healthcare products. Its Scientific, Technical & Medical segment provides scientific and medical information and data sets for science and healthcare. The Legal segment provides legal, regulatory, and business information and analytics. Its Exhibitions segment combines digital tools and data to help customers connect in-person and online, discover new markets, source products, generate leads, and transact. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.

Strong Buy 1.0 / 5 2 analysts
$32.69
$-0.04 (-0.12%)
Target: $52.45 (60.4%)
Sign in to add RELX to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$54.92B
P/E Ratio (TTM)21.20
Forward P/E14.74
EPS (TTM)$1.48
Dividend Yield2.86%
Profit Margin21.53%
Revenue Growth1.20%
ROE70.51%
Debt/Equity304.06
Recommendation Strong Buy 1.0
Analyst Target$52.45
Analysts2
Indexes NYSE

Technical Indicators

RSI (14)29.1
Beta0.25
SMA 20-
SMA 40-
52-Week High$54.30
52-Week Low$27.57
50-Day Avg$33.66
200-Day Avg$37.86
Avg Volume$2.66M
Volume$1.75M

Performance Analysis

BULLISH

RELX shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 19% of its 52-week range.
+ RSI at 29.1 signals oversold conditions — a bounce may be ahead.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
~ Modest revenue growth of 1.2% year-over-year.
+ Healthy profit margin of 21.5%.
+ Wall Street consensus is "Strong Buy" from 2 analysts.
+ Average analyst target of $52.45 implies 60.4% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:28 UTC

Back to Screener Export Report